These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16452193)

  • 1. GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.
    Huggins GS; Wong JY; Hankinson SE; De Vivo I
    Cancer Res; 2006 Feb; 66(3):1384-90. PubMed ID: 16452193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
    De Vivo I; Hankinson SE; Colditz GA; Hunter DJ
    Cancer Res; 2003 Sep; 63(17):5236-8. PubMed ID: 14500352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
    Yu KD; Chen AX; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
    Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
    Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.
    Beisner J; Buck MB; Fritz P; Dippon J; Schwab M; Brauch H; Zugmaier G; Pfizenmaier K; Knabbe C
    Cancer Res; 2006 Aug; 66(15):7554-61. PubMed ID: 16885354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.
    Feigelson HS; Rodriguez C; Jacobs EJ; Diver WR; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1084-5. PubMed ID: 15184270
    [No Abstract]   [Full Text] [Related]  

  • 8. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.
    De Vivo I; Huggins GS; Hankinson SE; Lescault PJ; Boezen M; Colditz GA; Hunter DJ
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12263-8. PubMed ID: 12218173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
    Cai Q; Gao YT; Wen W; Shu XO; Jin F; Smith JR; Zheng W
    Cancer Res; 2003 Sep; 63(18):5727-30. PubMed ID: 14522892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
    Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
    Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A;
    Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific GATA-binding elements in the GnRH promoter are required for gene expression pulse activity: role of GATA-4 and GATA-5 in this intermittent process.
    Leclerc GM; Bose SK; Boockfor FR
    Neuroendocrinology; 2008; 88(1):1-16. PubMed ID: 18259093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGR +331 A/G and increased risk of epithelial ovarian cancer.
    Risch HA; Bale AE; Beck PA; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1738-41. PubMed ID: 16985038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
    Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
    Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
    Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the NADPH oxidase isoform, Nox1, in colon epithelial cells: role of GATA-binding factor(s).
    Brewer AC; Sparks EC; Shah AM
    Free Radic Biol Med; 2006 Jan; 40(2):260-74. PubMed ID: 16413408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
    Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.